Rapid commentary : Ethical implications for clinical trialists and patients associated with COVID-19 research
©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved..
Pandemics disrupt clinical trials worldwide, with lasting effects on research. It can severely impact clinical trialists ability to conduct safe and ethically uncompromised trials. Hence, the mounting pressure results in ethically and morally distressing decisions faced by clinical trial professionals during pandemic situations. Whilst clinical trialists attempt to think about preparedness and responses during a pandemic, the need to have an ethical framework that has real-world applicability is imperative. Pandemics are a challenging time for all, however, the safety and access to support for clinical trialists and patients within clinical trials should be at the forefront for their organisations and the government.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:11 |
|---|---|
| Enthalten in: |
World journal of psychiatry - 11(2021), 3 vom: 19. März, Seite 58-62 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Delanerolle, Gayathri [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
COVID-19 |
|---|
| Anmerkungen: |
Date Revised 23.03.2021 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.5498/wjp.v11.i3.58 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM323041744 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM323041744 | ||
| 003 | DE-627 | ||
| 005 | 20231225183322.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.5498/wjp.v11.i3.58 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1076.xml |
| 035 | |a (DE-627)NLM323041744 | ||
| 035 | |a (NLM)33747803 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Delanerolle, Gayathri |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Rapid commentary |b Ethical implications for clinical trialists and patients associated with COVID-19 research |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 23.03.2021 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a ©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. | ||
| 520 | |a Pandemics disrupt clinical trials worldwide, with lasting effects on research. It can severely impact clinical trialists ability to conduct safe and ethically uncompromised trials. Hence, the mounting pressure results in ethically and morally distressing decisions faced by clinical trial professionals during pandemic situations. Whilst clinical trialists attempt to think about preparedness and responses during a pandemic, the need to have an ethical framework that has real-world applicability is imperative. Pandemics are a challenging time for all, however, the safety and access to support for clinical trialists and patients within clinical trials should be at the forefront for their organisations and the government | ||
| 650 | 4 | |a Editorial | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a Clinical trials | |
| 650 | 4 | |a Ethics | |
| 650 | 4 | |a Pandemic | |
| 650 | 4 | |a Patients | |
| 650 | 4 | |a Trialists | |
| 700 | 1 | |a Rathod, Shanaya |e verfasserin |4 aut | |
| 700 | 1 | |a Elliot, Kathryn |e verfasserin |4 aut | |
| 700 | 1 | |a Ramakrishnan, Rema |e verfasserin |4 aut | |
| 700 | 1 | |a Thayanandan, Tony |e verfasserin |4 aut | |
| 700 | 1 | |a Sandle, Natasha |e verfasserin |4 aut | |
| 700 | 1 | |a Haque, Nyla |e verfasserin |4 aut | |
| 700 | 1 | |a Raymont, Vanessa |e verfasserin |4 aut | |
| 700 | 1 | |a Phiri, Peter |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t World journal of psychiatry |d 2011 |g 11(2021), 3 vom: 19. März, Seite 58-62 |w (DE-627)NLM232149526 |x 2220-3206 |7 nnns |
| 773 | 1 | 8 | |g volume:11 |g year:2021 |g number:3 |g day:19 |g month:03 |g pages:58-62 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.5498/wjp.v11.i3.58 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 11 |j 2021 |e 3 |b 19 |c 03 |h 58-62 | ||